Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland

Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland

Aim The aim of this study was to assess the cost effectiveness of the Pill Protect (PP) genetic screening test for venous thromboembolism (VTE) risk compared with standard of care (SoC), for women considering combined hormonal contraceptives (CHCs) in Switzerland.Methods A two-part microsimulation m...

Full description

Saved in:
Bibliographic Details
Main Authors: Zanfina Ademi, C Simone Sutherland, Matthias Schwenkglenks, Nadine Schur, Joëlle Michaud, Myriam Lingg, Arjun Bhadhuri, Thierry D. Pache, Johannes Bitzer, Pierre Suchon, Valerie Albert, Kurt E. Hersberger, Goranka Tanackovic
Format: Article
Language:English
Published: BMJ Publishing Group 2019-11-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/9/11/e031325.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/9/11/e031325.full

Similar Items